Transwell assays showed the migration and invasion ability was consistently decreased in the U87 and U251 cell lines after ECM2 knockdown, indicating the important role of the ECM2 gene in the pathogenesis and development of gliomas. Here, ECM2 is linked to central nervous system cancer.